Percy H Carter

8PUBLICATIONS
30CO-AUTHORS
Powder and particle technologyMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesBiocatalysis and enzyme technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 23, 2024
Challenges with the Synthesis of a Macrocyclic Thioether Peptide: From Milligram to Multigram Using Solid Phase Peptide Synthesis (SPPS).

James Kempson, Rulin Zhao, Joseph Pawluczyk

|Nov 28, 2023
Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5.

John R D Dawson, Grant M Wadman, Penglie Zhang

|Nov 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate.

Robert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar

|Oct 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy.

David Marcoux, James J-W Duan, Qing Shi

|Jul 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.

Stephen T Wrobleski, Ryan Moslin, Shuqun Lin

|Jul 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2).

Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski

Pageof 2

Frequent Collaborators

2 joint publications

T G Murali Dhar

2 joint publications

Anuradha Gupta

2 joint publications

James Kempson

2 joint publications

Steven Spergel